Company
Headquarters: Lund, Sweden
Employees: 11
CEO: Mr. Christer Fahraeus B.Sc. Maths, h.c., MSc Bio Eng, Ph.D.
€145.9 Million
EUR as of July 1, 2024
US$156.7 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
EQL Pharma AB (publ) engages in the development, marketing, and sale of specialty and generic medicines to pharmacies and hospitals in Europe. The company was incorporated in 2006 and is based in Lund, Sweden.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
EQL Pharma AB has the following listings and related stock indices.
Stock: FSX: 7JK wb_incandescent